Mirjam E. Kuipers
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Virology top 10%
- HIV Research and Treatment
Papers in
- Virology 5
- HIV Research and Treatment 5
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Dirk K. F. Meijer (12 shared papers)Hendrik G. de Vries (2 shared papers)Walter J. J. Krauwinkel (4 shared papers)Barbara Sarholz (4 shared papers)Leonie Beljaars (5 shared papers)Ronald A. Smulders (3 shared papers)Maja J.A. de Jonge (2 shared papers)Erik De Clercq (3 shared papers)
- Journals
- Biochemical Pharmacology (2 papers)Journal of Peptide Science (2 papers)Antiviral Research (1 paper)Journal of Hepatology (1 paper)Pharmaceutical Research (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Mirjam E. Kuipers
24 papers receiving 629 citations
Peers
Comparison fields: 5 of 71
- Microbiology 91
- Virology 39
- Urology 44
- Pharmaceutical Science 42
- Infectious Diseases 95
Countries citing papers authored by Mirjam E. Kuipers
This map shows the geographic impact of Mirjam E. Kuipers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam E. Kuipers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam E. Kuipers more than expected).
Fields of papers citing papers by Mirjam E. Kuipers
This network shows the impact of papers produced by Mirjam E. Kuipers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam E. Kuipers. The network helps show where Mirjam E. Kuipers may publish in the future.
Co-authors
The 25 scholars most cited alongside Mirjam E. Kuipers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 127 | |
| 2 | 2020 | 95 | |
| 3 | 2023 | 44 | |
| 4 | 1996 | 40 | |
| 5 | 1999 | 39 | |
| 6 | 1999 | 31 | |
| 7 | 1999 | 28 | |
| 8 | 2002 | 28 | |
| 9 | 2004 | 27 | |
| 10 | 1999 | 26 | |
| 11 | 2023 | 23 | |
| 12 | 2006 | 19 | |
| 13 | 1995 | 18 | |
| 14 | 1999 | 17 | |
| 15 | 2002 | 16 | |
| 16 | 1999 | 15 | |
| 17 | 2018 | 15 | |
| 18 | 2005 | 13 | |
| 19 | 1997 | 11 | |
| 20 | 2005 | 11 |
About Mirjam E. Kuipers
Mirjam E. Kuipers is a scholar working on Virology, Pharmacology, Microbiology, Molecular Biology and Oncology, having authored 24 papers that have together received 658 indexed citations. Recurring topics across this work include Protein Interaction Studies and Fluorescence Analysis (7 papers), HIV Research and Treatment (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Antimicrobial Peptides and Activities (3 papers), Antifungal resistance and susceptibility (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Urinary Bladder and Prostate Research (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Microbiology (91 citations), Virology (39 citations), Urology (44 citations), Pharmaceutical Science (42 citations) and Infectious Diseases (95 citations). Mirjam E. Kuipers has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Dirk K. F. Meijer, Hendrik G. de Vries, Walter J. J. Krauwinkel, Barbara Sarholz, Leonie Beljaars, Ronald A. Smulders, Maja J.A. de Jonge, Erik De Clercq, Henk M.W. Verheul and Rudi Pauwels. Their work appears in journals such as Biochemical Pharmacology, Journal of Peptide Science, Antiviral Research, Journal of Hepatology and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.